Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SI

WKN: A2DW24 | ISIN: SE0008091664 | Ticker: 5LU
Frankfurt
18.11.26 | 20:15
0,004 Euro
+28,57 % +0,001
1-Jahres-Chart
SIMRIS GROUP AB Chart 1 Jahr
5-Tage-Chart
SIMRIS GROUP AB 5-Tage-Chart

Aktuelle News zur SIMRIS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.11.Simris Group AB: Simris Group Interim Report January-september 2026130QUARTER 3, JULY - SEPTEMBER 2026Net revenue decreased by 51% to SEK 236k (484k).EBITDA decreased by 16% to SEK -4 229k (-3 639k).EBIT/Operating result decreased by 8% to SEK -7 727k (-7 152k).INTERIM...
► Artikel lesen
29.10.Simris Group AB: Simris Group Appoints Experienced Adc Clinical Development Leader Dr. András Strassz As Chief Medical Officer229Simris Group AB (publ) ("Simris" or the "Company") announces the appointment of Dr. András Strassz as Chief Medical Officer (CMO). The appointment marks the next step in delivering the Company's recently...
► Artikel lesen
07.10.Simris Group AB: Simris Group enters into new MoU with Immunrise Biocontrol for lease and subsequent acquisition of Hammenhög facility443Simris Group AB ("Simris" or the "Company") announces that it has entered into a new Memorandum of Understanding ("MoU") with Immunrise Biocontrol France SAS ("Immunrise") regarding the lease and subsequent...
► Artikel lesen
12.08.Simris Group AB: Simris Group Interim Report January-june 2026270QUARTER 2, APRIL - JUNE 2026Net revenue decreased by 71% to SEK 196k (687k).EBITDA improved by 35% to SEK -1 927k (-2 980k).EBIT/Operating result improved by 19% to SEK -5 437k (-6 693k).INTERIM PERIOD...
► Artikel lesen
15.07.Simris Group AB: Simris Group Ab Appoints Adc Expert Professor Andreas Pahl As Chief Executive Officer Of Its Subsidiary Simris Biologics Gmbh499Simris Group AB (SIMRIS B) today announced the appointment of Professor Andreas Pahl as Chief Executive Officer of Simris Biologics GmbH, its wholly owned subsidiary based in Berlin, Germany. Professor...
► Artikel lesen
SIMRIS GROUP Aktie jetzt für 0€ handeln
24.06.Simris Group AB: Bulletin from Simris Group AB's annual general meeting303Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 24 June 2026. Below follows a summary of the resolutions that were passed at the general meeting Income...
► Artikel lesen
13.05.Simris Group AB: Simris Group Interim Report January-march 2026358QUARTER 1, JANUARY - MARCH 2026Net revenue increased by 167% to SEK 424k (159k).EBITDA improved by 41% to SEK -2 183k (-3 724k).EBIT/Operating result improved by 23% to SEK -5 626k (-7 288k).KEY EVENTS...
► Artikel lesen
12.05.Simris Group AB: Simris Group Advances Asset Divestment Process with Two Prospective Buyers538Simris Group AB (Simris or the Company) today announces progress in its strategic divestment process for its microalgae production facility in Hammenhög, Sweden. Simris has entered into a Memorandum...
► Artikel lesen
11.03.Simris Group AB: Simis provides an update on the divestment of its assets in Hammenhög, Sweden341Simris Group AB ("Simris" or the "Company") announces that discussions with Immunrise Biocontrol France SAS ("Immunrise") continue, on a non-exclusive basis, beyond the deadline of March 1, 2026 and...
► Artikel lesen
28.02.Simris Group AB: Simris Group Year-end Report January-december 2025649QUARTER 4, JULY - DECEMBER 2025Net revenue decreased by 71% to SEK 285k (971k).EBITDA declined by 63% to SEK -5 196k (-3 180k).EBIT/Operating result improved by 9% to SEK -8 429 (-9 241k).YEAR-END PERIOD...
► Artikel lesen
19.01.Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting442Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting. Election...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1